hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial Tumors

Clinical trial NCT05157594 · COMPLETED

Trial details

NCT number: NCT05157594
Sponsor: Centre Jean Perrin
Status: COMPLETED
Study type: OBSERVATIONAL

Glial Cell Tumors

Start date: 2022-02-14
Primary completion: 2025-08-19
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.